Exclusive: Private equity firms circling Nestle's skin health business - sources
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Johnson & Johnson (JNJ) PT Lowered to $144 at RBC Capital
January 23, 2019 6:53 AM ESTRBC Capital analyst Glenn Novarro lowered the price target on Johnson & Johnson (NYSE: JNJ) to $144.00 (from $155.00) while maintaining a Outperform rating.
Novarro notes management has set conservative 2019 guidance. As such, he expects the 'beat and raises' to continue.
... More